Competitive Price for Salicylic Acid - Diosmin – Chenlv Detail:
CAS number: 520 -27 - 4
Product sources: hesperidin
Appearance: white or off-white fine powder
Molecular Formula: C28H32O15
Molecular Weight: 608.5
Test method: HPLC
Specification: EP8.0 Diosmin90.0%-101.0%
What is Diosmin?
Diosmin is a type of plant chemical found mainly in citrus fruits. People use diosmin to make medicine.
Diosmin is used for treating various disorders of blood vessels including hemorrhoids, varicose veins, poor circulation in the legs (venous stasis), and bleeding (hemorrhage) in the eye or gums. It is also used to treat swelling of the arms (lymphedema) following breast cancer surgery, and to protect against liver toxicity. It is often taken in combination with hesperidin, another plant chemical.
Effective
Treating hemorrhoids and preventing recurrence, when used in combination with hesperidin.
Treating leg ulcers caused by poor circulation, when used in combination with hesperidin.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
We believe in: Innovation is our soul and spirit. Quality is our life. Shopper need is our God for Competitive Price for Salicylic Acid - Diosmin – Chenlv, The product will supply to all over the world, such as: Costa rica , Holland , Durban , Insisting on the high quality generation line management and customers expert assistance, we now have designed our resolution to supply our buyers using the to start with amount getting and just after services practical experience. Maintaining the prevailing friendly relations with our buyers, we however innovate our solution lists all of the time to satisfy the brand new demands and adhere to the most up-to-date development of the market in Malta. We have been ready to face the worries and make the improve to understand all the possibilities in international trade.
By Chloe from Finland - 2018.12.28 15:18
Products and services are very good, our leader is very satisfied with this procurement, it is better than we expected,
By Sharon from Boston - 2017.04.18 16:45